###begin article-title 0
Amyloid precursor family proteins are expressed by thymic and lymph node stromal cells but are not required for lymphocyte development
###end article-title 0
###begin p 1
###xml 0 19 0 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Transmitting editor</italic>
Transmitting editor: Stephen M. Hedrick
###end p 1
###begin p 2
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
Pharmacological inhibitors that block amyloid precursor protein (APP) cleavage and the formation of senile plaques are under development for the treatment of familial Alzheimer's disease. Unfortunately, many inhibitors that block gamma-secretase-mediated cleavage of APP also have immunosuppressive side effects. In addition to APP, numerous other proteins undergo gamma-secretase-mediated cleavage. In order to develop safer inhibitors, it is necessary to determine which of the gamma-secretase substrates contribute to the immunosuppressive effects. Because APP family members are widely expressed and are reported to influence calcium flux, transcription and apoptosis, they could be important for normal lymphocyte maturation. We find that APP and amyloid precursor-like protein 2 are expressed by stromal cells of thymus and lymph nodes, but not by lymphocytes. Although signals provided by thymic stromal cells are critical for normal T cell differentiation, lymphocyte development proceeds unperturbed in mice deficient for these APP family members.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 661 662 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 663 664 641 642 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
###xml 769 777 743 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 779 780 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 781 782 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
The major protein component of the senile plaques associated with familial Alzheimer's disease is the Abeta peptide that is generated when amyloid precursor protein (APP) undergoes sequential beta- and gamma-secretase-mediated cleavages. There has been a great deal of interest in the use of pharmacological gamma-secretase inhibitors for treatment of Alzheimer's disease, based on the hypothesis that preventing cleavage of APP could potentially cure the disease. Unfortunately, gamma-secretase inhibitors can have immunosuppressive side effects. Inclusion of gamma-secretase inhibitors in fetal thymus organ cultures profoundly blocked thymocyte development (1,2). Moreover, gamma-secretase inhibitors impaired proliferation and cytokine production by mature T cells in vitro (3-7).
###end p 4
###begin p 5
###xml 221 222 213 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 223 225 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 583 585 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
Numerous proteins undergo gamma-secretase-mediated cleavage including APPs, Notch 1-4, Delta1, Jagged2, CD44, ErbB4, E-cadherin, lipoprotein receptor-related protein (LRP), Nectin-1alpha and chemokines CX3CL1 and CXCL16 (8-18). These proteins are variably expressed in lymphocytes and lymphoid-associated stromal cells. The gamma-secretase inhibitors that were used in experiments for impairing T cell responses and development are transition state analogs that bind to the active site of the gamma-secretase complex, so as to inhibit the cleavage of all gamma-secretase substrates (19). Because both lymphocytes and stromal cells express proteins that are gamma-secretase substrates, it remains to be determined whether the adverse effects of the inhibitors reflect a direct effect on lymphocytes themselves or an effect on the stromal cells that direct lymphocyte maturation and/or activation. Thus, it is important to determine which substrates and cell types are associated with gamma-secretase-mediated inhibition of lymphocyte development and function.
###end p 5
###begin p 6
###xml 232 234 228 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 235 237 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 317 319 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 320 322 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 323 325 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 420 422 412 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 423 425 415 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib28">28</xref>
###xml 557 559 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 560 562 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 563 565 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 627 629 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 630 632 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 641 643 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 646 654 638 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">disabled</italic>
###xml 665 667 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 686 688 678 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 696 698 688 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 712 713 704 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 715 717 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib38">38</xref>
###xml 726 728 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib39">39</xref>
###xml 780 782 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 977 979 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib35">35</xref>
###xml 980 982 972 974 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
###xml 1072 1074 1064 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 1102 1104 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib40">40</xref>
###xml 1135 1137 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 1138 1140 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 1141 1143 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 1144 1146 1136 1138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 1285 1287 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 1407 1409 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
Prominent among the gamma-secretase substrates is the APP family, consisting of three highly homologous proteins, APP and amyloid precursor-like proteins 1 and 2 (APLP1, APLP2). APLP1 expression is restricted to the nervous system (20,21). In contrast, APP and APLP2 mRNA are found in many tissues, including thymus (20,22-26). Cleavage of APP, APLP1 or APLP2 by gamma-secretase releases a small intracellular fragment (27,28) which can associate with numerous cytosolic proteins including nuclear adaptor protein Fe65 and histone acetyl transferase Tip60 (27,29-32), scaffolding protein Jnk-interacting protein 1 (JIP1, IB1) (33,34), Grb2 (35), disabled 1 (DAB1) (36), heme oxygenase (37), X11 (29), G protein G0 (38), ShcA (39) and Notch inhibitory proteins Numb and Numb-like (40). Although the true physiological role of APP proteins remains elusive, the intracellular domain of APP has been shown to modulate phosphoinositide-mediated calcium flux and MEK/ERK activation (35,41), trigger apoptosis directly or enhance sensitivity of cells to other apoptotic stimuli (42), inhibit Notch signaling (40) and stimulate transcription (27,31,43,44). Notably, intracellular fragments of APP and Notch can co-localize in nuclear structures postulated to be sites of active transcription (45), and it is well established that Notch functions are important for T cell commitment, differentiation and maturation (46). Given the potential for cross-talk between APP and Notch in nuclear signaling and the finding that APP and APLP2 mRNA are expressed in lymphoid tissues, it is surprising that APP family proteins have not yet been studied in the immune system.
###end p 6
###begin p 7
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 699 703 <span type="species:ncbi:10090">mice</span>
Here we have investigated the expression and function of APP family proteins in developing T cells. We find that APP and APLP2 proteins are expressed in thymus and lymph nodes (LNs), but exclusively by the stromal cells. These results preclude a functional role for these proteins in thymocytes themselves. Nevertheless, because thymocyte development and selection is absolutely dependent on signals provided by thymic stromal cells, it was possible that APP/APLP2 expression by stromal cells was required to support normal thymocyte development. However, studies of T cell development in mice deficient for APP, APLP2 or both revealed that T cell development proceeded unperturbed. Moreover, these mice had normal populations of peripheral T and B cells. While the physiological significance of the stromal cell expression remains to be determined, our results indicate that the defects in T lymphocyte maturation associated with gamma-secretase inhibition do not involve APP family proteins.
###end p 7
###begin title 8
Methods
###end title 8
###begin title 9
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and genotyping
###end title 9
###begin p 10
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 879 882 879 882 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 915 918 915 918 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">Mice</span>
###xml 540 544 <span type="species:ncbi:10090">Mice</span>
APP- and APLP2-deficient (germline null mutant) mice have been previously described (47,48) and were generously provided by Merck Research Laboratories (Rahway, NJ, USA) and Robert Cappai (University of Melbourne, Australia), respectivelyC57BL/6 (B6) mice were obtained from National Cancer Institute-Frederick. Mice were bred and maintained under specific pathogen-free conditions in National Institute of Allergy and Infectious Diseases (NIAID) Research Animal Facilities on protocols approved by the NIAID Animal Care and Use Committee. Mice were genotyped by PCR using the following primers: APLP2 forward 5'-ctgctgcaggtgg ctctgca-3', APLP2 reverse 5'-cag ctctatacaag caaacaag-3'; APP forward 5'-ctgctgcaggtgg ctctgca-3', APP reverse 5'-cag ctctatacaagcaaa caag-3', and PGKNeo reverse 5'-cattgctcagcggt gctgt-3'. The expected fragments are APLP2 wild type (WT), 400 bp; APLP2-/-, 350 bp; APP WT, 250 bp, and APP-/-, 470 bp.
###end p 10
###begin title 11
Lymphocyte isolation
###end title 11
###begin p 12
###xml 171 177 170 176 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">lo/neg</sup>
###xml 358 364 <span type="species:ncbi:9986">Rabbit</span>
Lymphocytes were isolated from thymus and LNs. Single-cell suspensions were generated using 100 mum nylon mesh (PGC Scientifics, Garner, NC, USA). To enrich for mature HSAlo/neg thymocytes, single-cell suspensions of total thymocytes were incubated at 37degrees for 30 min with an anti-HSA (J11d) culture supernatant, a 1:10 dilution of Cedar Lane Low-Tox-M Rabbit Complement (Accurate Chemical & Scientific Corp., Westbury, NY, USA) and DNAse (Calbiochem, San Diego, CA, USA). After complement-mediated lysis, the remaining cells were washed twice with media and passed over a Ficoll gradient to remove dead cells and debris.
###end p 12
###begin title 13
Antibodies
###end title 13
###begin p 14
Antibodies used for immunofluorescence analysis were purchased from BD PharMingen (San Diego, CA, USA): anti-CD3epsilon-CyC or -APC (145-2C11); anti-CD4-CyC (RM4-5); anti-CD8-CyC or -APC (53-6.7), anti-CD19-PE (1D3); anti-CD25-FITC (7D4); anti-CD44-APC, or -biotin (IM7); anti-CD45-FITC (30-F11); anti-CD45R-CyC (RA3-6B2); anti-TCRgammadelta-PE (GL3); anti-TCRbeta-FITC or -PE (H57.597); anti-IgD-FITC (11-26c.2a). A cocktail used to determine lineage negative (Lin-) thymocytes contained antibodies to CD4, CD8, CD19, TCRalphabeta and TCRgammadelta, all labeled with PE. Anti-CD4-PE (GK1.5) was purchased from Becton Dickinson Collaborative Technologies (Bedford, MA, USA). Anti-IgM-biotin was purchased from Kirkegaard & Perry Laboratories (Gaithersburg, MD, USA). Annexin V-FITC, propidium iodide and anti-CD8alpha-FITC or -PE (CT-CD8) were purchased from Caltag Laboratories (South San Francisco, CA, USA). Biotin-conjugated antibodies were visualized with streptavidin-Cy5 (Jackson ImmunoResearch Laboratories, Inc., West Grove, PA, USA). For microscopy, a purified anti-CD4 (BD PharMingen) was labeled with Alexa488 dye using a labeling kit (Molecular Probes/Invitrogen, Carlsbad, CA, USA).
###end p 14
###begin title 15
Flow cytometry
###end title 15
###begin p 16
###xml 81 82 81 82 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
A single-cell suspension of lymphocytes in HBSS, containing 0.2% BSA and 0.1% NaN3, was incubated with properly diluted antibody at 4degreesC for 20 min. After staining, cells were washed twice with the same buffer and relative fluorescence was measured by flow cytometry using a FACS Calibur and Cell Quest Software (Becton Dickinson, San Jose, CA, USA).
###end p 16
###begin title 17
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro survival assay
###end title 17
###begin p 18
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 39 41 39 41 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Thymocytes were plated at 1-1.5 x 106ml-1 in RPMI supplemented with 10% FCS and cultured at 37degreesC. The number of live cells remaining was calculated daily. Live cells were identified based upon their ability to exclude Trypan Blue.
###end p 18
###begin title 19
Protein lysates and western blotting
###end title 19
###begin p 20
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 146 147 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 592 593 579 580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
Single-cell suspensions or whole lymphoid tissues were lysed in buffer containing 20 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1% NP-40, 1 mM Na3VO4 and protease inhibitors (Roche complete tablets; Roche Applied Science, Indianapolis, IN, USA). Samples were incubated on ice for >30 min, inverting every 10 min to mix, and spun for 5 min at 12 000 r.p.m. at 4degreesC. Supernatants were stored at -80degreesC. For single-cell suspensions, thymus or LNs were crushed and filtered through 100 mum nylon mesh to remove connective tissue, resulting in a single-cell suspension containing >95% CD45+ hematopoietic cells. For lysates of whole organs, intact thymus, LN or brain were homogenized in lysis buffer using a mortar and pestle, generating lysates composed of both connective tissue and hematopoietic cells.
###end p 20
###begin p 21
###xml 661 663 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 712 718 <span type="species:ncbi:9986">rabbit</span>
###xml 739 743 <span type="species:ncbi:9925">goat</span>
Lysates were subjected to PAGE on Novex 8-12% NuPAGE gels with MES buffer (Invitrogen), and transferred to Hybond-P PVDF membranes (Amersham Pharmacia Biotech, Piscataway, NJ, USA). After blocking with 5% non-fat dried milk in PBS/0.01% Tween 20, blots were hybridized overnight at 4degreesC with polyclonal antisera in PBS/0.01% Tween 20 with 2.5% non-fat dried milk. Anti-APLP1 (CT11) and anti-APLP2 (D2-II) were purchased from Calbiochem. Anti-CD3epsilon (M-20) and anti-beta-tubulin (H-235) were purchased from Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA). Anti-APP/APLP (B10.4) and anti-APP (B62.1) were developed as previously described for B10.4 (49). Secondary antibodies were HRP-conjugated anti-rabbit IgG (Roche) or anti-goat Ig (Jackson ImmunoResearch Laboratories, Inc.). Blots were developed with ECL western blotting analysis system (Amersham Pharmacia Biotech) or SuperSignal West Dura Extended Duration Substrate (Pierce, Rockford, IL, USA).
###end p 21
###begin title 22
Histology
###end title 22
###begin p 23
###xml 438 439 438 439 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 519 523 <span type="species:ncbi:9925">goat</span>
###xml 647 651 <span type="species:ncbi:9925">goat</span>
###xml 774 780 <span type="species:ncbi:9986">rabbit</span>
###xml 796 799 <span type="species:ncbi:9685">Cat</span>
###xml 864 869 <span type="species:ncbi:10090">mouse</span>
Thymuses were fixed with a 4% PFA solution in PBS, then washed with PBS and treated with 20% sucrose solution in PBS. After washing, thymuses were immersed in O.C.T. compound (Tissue Tek) for 1 h and snap-frozen using a mixture of 2-methylbutane (Sigma-Aldrich, St Louis, MO, USA) and dry ice. Ten micrometer sections were obtained using a cryostat. The sections were fixed with 4% PFA for 15 min, washed with PBS, incubated with 50 mM NH4Cl for 10 min, washed with PBS and blocked with a solution containing 5% normal goat serum, 3% BSA and 0.2% Triton X-100. Sections were incubated overnight with anti-APLP2 (D2-II) in PBS containing 5% normal goat serum and 3% BSA and then washed with PBS. Sections were stained 4 h with anti-CD4-Alexa-488, anti-CD8alpha-APC, and anti-rabbit IgG-Alexa-568 (Cat. no. A-11036, Molecular Probes) that was used to visualize anti-mouse APLP2, and washed with PBS. Sections were mounted with ProLong Antifade (Molecular Probes), and immunofluorescence was analysed using a Leica LSR confocal microscope.
###end p 23
###begin title 24
Statistical analyses
###end title 24
###begin p 25
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
All two-tailed Student's t-tests were conducted using InStat Instant Biostatistics (GraphPad Software; San Diego, CA, USA). Error bars represent SEM.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
APP and APLP2 proteins are expressed in thymus and LNs
###end title 27
###begin p 28
###xml 44 46 44 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 50 52 50 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 258 261 258 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 266 269 266 269 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 276 279 276 279 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 286 289 286 289 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 294 297 294 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 446 452 446 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 1084 1085 1084 1085 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 1088 1089 1088 1089 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1096 1097 1096 1097 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1101 1102 1101 1102 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 332 338 <span type="species:ncbi:9986">rabbit</span>
APP and APLP2 mRNA are expressed in thymus (20,22-26). To determine which thymic cell type(s) express APP family proteins, APP, APLP1 and APLP2 proteins were analysed by western blotting. Lysates made from thymus cell suspensions or intact brain of adult APP+/-, APP-/-, APLP2-/- or APP-/-APLP2-/- mice were blotted with polyclonal rabbit sera raised against APP, APLP2 or APLP1. As expected, all three homologues were highly expressed in brain (Fig. 1). Consistent with previous reports that APLP1 expression is restricted to the nervous system, APLP1 was never observed in thymus lysates. Surprisingly, APP was not detected in thymocyte lysates under any conditions tested. In most analyses, APLP2 was also undetectable. However, in cases where a super sensitive extended duration substrate and long exposure times were used (see Methods), a faint APLP2 band was visualized in lysates made from large numbers of thymocytes. This result was consistent with either extremely low expression by many thymocytes or high expression by a minor fraction of cells, for example, by mature CD4+CD8- or CD4- CD8+ single-positive (SP) thymocytes which account for approximately10% of total thymocytes.
###end p 28
###begin p 29
###xml 162 163 162 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sup>
###xml 178 179 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sup>
###xml 215 216 215 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">o</sup>
###xml 332 338 332 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">neg/lo</sup>
###xml 490 491 483 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 503 504 496 497 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 135 139 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
APP and APLP2 are expressed by non-lymphoid cells in thymus and LN. To assess protein expression by western blot analysis, WT mice and mice deficient for APP (APPo), APLP2 (APLP2o) or APP/APLP2 double-deficient (Dblo) mice were used to obtain (A) cell suspensions of thymocytes and intact brain, (B) cell suspensions of total or HSAneg/lo thymocytes, intact thymus (which include stromal cells) or brain or (C) cell suspensions of B6 LNs (pre-sort) electronically sorted for T (TCRalphabeta+) or B (CD19+) cells, intact B6 LNs (which include stromal cells) or intact brain. Blots were hybridized with antisera against APP/APLP, APP, APLP1 or APLP2, as designated, or with anti-CD3ϵ and anti-beta-tubulin for loading controls.
###end p 29
###begin p 30
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 241 243 241 243 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 494 503 482 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1(B)</xref>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 285 291 <span type="species:ncbi:9986">rabbit</span>
Since thymocytes gradually downregulate expression of HSA (CD24) as they mature (50), we used this marker to isolate mature thymocytes for assay of APLP2 expression. Thymocytes of APP+/-, APP-/- or APLP2-/- mice were depleted of immature HSAhi cells using anti-HSA antibody (J11d) and rabbit complement. Prior to enrichment, thymocyte populations contained approximately10% CD4 or CD8 SP thymocytes. After complement-mediated lysis, thymocytes were >90% mature SP (data not shown). As shown in Fig. 1(B), APLP2 expression was not enriched in lysates of SP thymocytes, making it unlikely that the faint band was due to a late onset of APLP2 expression in the most mature thymocytes.
###end p 30
###begin p 31
###xml 440 443 440 443 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 476 479 476 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 483 486 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 554 557 554 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 564 567 564 567 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 574 581 574 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1B</xref>
###xml 488 492 <span type="species:ncbi:10090">mice</span>
###xml 568 572 <span type="species:ncbi:10090">mice</span>
Very few thymic stromal cells are recovered in thymocyte cell suspensions, whereas virtually all thymocytes and stromal cells are recovered if the intact thymus organ is used for preparing protein lysates. Thus, it was conceivable that the low level of APLP2 detected in lysates of thymocyte suspensions derived only from stromal cells. Indeed, lysates blotted for APP or APLP2 revealed a strong band for APLP2 using whole thymus of B6, APP-/- or recombination-activating gene-/-(RAG-/-) mice and only a faint band for APP using whole thymus of B6, APLP2-/- or RAG-/- mice (Fig. 1B). These results suggested that thymic stromal cells express high levels of APLP2 and low levels of APP proteins, whereas thymocytes express neither family member.
###end p 31
###begin p 32
###xml 185 191 185 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1</xref>
###xml 230 236 230 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2</xref>
###xml 345 352 345 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2A</xref>
###xml 469 476 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2D</xref>
###xml 590 597 590 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2B</xref>
To confirm the expression of APLP2 by thymus stromal cells, histological sections of WT B6 thymuses were stained with the same anti-APLP2-specific antisera used for western blotting in Fig. 1 and imaged using confocal microscopy (Fig. 2). Thymus cortex was identified by the presence of densely packed thymocytes co-expressing both CD4 and CD8 (Fig. 2A). The thymus medulla was identified by the presence of less densely packed thymocytes expressing either CD4 or CD8 (Fig. 2D). By these analyses, APLP2 was expressed throughout the thymus by both the cortical and medullary stromal cells (Fig. 2B,E). Consistent with the western blotting data, no co-localization of CD4 and APLP2 expression was observed, confirming that APLP2 expression was restricted to non-T lineage cells.
###end p 32
###begin p 33
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 690 696 <span type="species:ncbi:9986">rabbit</span>
APLP2 expression is localized to thymic stroma. Thymuses of WT B6 mice were fixed, sectioned and stained for co-expression of CD4 (green), CD8 (blue) and APLP2 (red). (A) The thymus cortex was identified by the presence of densely packed thymocytes co-expressing both CD4 and CD8. (B) Same image as in (A), showing immunofluorescence from anti-CD4 and anti-APLP2. (D) The thymus medulla was identified by the presence of less densely packed thymocytes expressing either CD4 or CD8. (E) Same image as in (D), showing immunofluorescence from anti-CD4 and anti-APLP2. (C and F) Serial sections of A/B or D/E, control showing immunofluorescence of anti-CD4 and secondary Alexa-586-labeled anti-rabbit-IgG without the primary anti-APLP2 antibody. Images were collected at x63 magnification on a Leica LSR confocal microscope.
###end p 33
###begin p 34
###xml 141 148 141 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1C</xref>
To determine the expression pattern of APP and APLP2 in secondary lymphoid tissue, lysates made from B6 LNs were blotted for these proteins (Fig. 1C). The expression pattern of APP and APLP2 in LNs was similar to that of thymus. Both proteins were undetectable in lysates prepared from LN cell suspensions, or highly purified populations of T or B cells. However, these proteins were present in lysates made from intact, whole LNs, indicating that APP and APLP2 were derived from stromal cells. Therefore, the findings are consistent with previous reports of APP and APLP2 mRNA expression in lymphoid organs, but results here reveal that this expression can be attributed to non-lymphoid stromal cells.
###end p 34
###begin title 35
Neither APP nor APLP2 are required for lymphocyte development from adult precursors
###end title 35
###begin p 36
###xml 440 446 440 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figs 1</xref>
###xml 451 452 451 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">2</xref>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 661 663 661 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">53</xref>
###xml 728 731 728 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 736 739 736 739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 894 896 894 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 897 899 897 899 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
###xml 1002 1004 1002 1004 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 1005 1007 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 1008 1010 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 1011 1013 1011 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">53</xref>
###xml 545 549 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">Mice</span>
###xml 740 744 <span type="species:ncbi:10090">mice</span>
###xml 790 794 <span type="species:ncbi:10090">mice</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
###xml 1037 1041 <span type="species:ncbi:10090">mice</span>
While we were unable to detect APP family protein expression in thymocytes, the possibility remained that these proteins performed some direct or indirect function in T cell development. Of relevance, thymic stromal cells are essential for promoting T cell differentiation; however, the signals they provide to developing thymocytes have not been fully defined. Therefore, the significance of high APLP2 expression by thymic stromal cells (Figs 1 and 2) was of particular interest. To pursue this issue, we investigated thymocyte development in mice deficient for APP family proteins. Mice with germline mutations in either APP or APLP2 have been described (47,48,51-53) and are grossly normal. In contrast, doubly deficient APP-/-APLP2-/- mice have >80% neonatal mortality rate, and those mice that survive to adulthood are sterile and have multiple neurological and behavioral abnormalities (48,52). While the central nervous system of APP- and/or APLP2-deficient mice have been extensively studied (47,48,51-53), lymphocytes of these mice have not been characterized.
###end p 36
###begin p 37
###xml 222 225 222 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 280 283 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 495 498 495 498 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 503 506 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 453 457 <span type="species:ncbi:10090">mice</span>
###xml 507 511 <span type="species:ncbi:10090">mice</span>
###xml 585 589 <span type="species:ncbi:10090">mice</span>
The more severe phenotype of double-deficient mice for APP and APLP2 demonstrates that these proteins are at least somewhat functionally redundant. To characterize thymocyte development in the absence of APP and APLP2, APP+/-APLP2-/- mice were intercrossed to generate APP-/-APLP2-/- animals. APP-/-APLP2-/- pups were born with less than the predicted 25% Mendelian frequency (20:54:15); moreover, very few survived to weaning at 3 weeks of age. Of 260 mice from 50 litters genotyped, only 5 APP-/-APLP2-/- mice survived to adulthood (94:161:5). Compared with control littermates, the mice that survived were smaller in overall body size and weight, failed to breed, appeared agitated and exhibited neurological problems such as forelimb weakness, spinning and difficulty righting.
###end p 37
###begin p 38
###xml 194 197 194 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 202 205 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 212 219 212 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3A</xref>
###xml 224 231 224 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 686 693 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 866 873 866 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3B</xref>
###xml 1122 1129 1122 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3B</xref>
###xml 1157 1160 1157 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1165 1168 1165 1168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1238 1245 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="tbl1">Table 1</xref>
###xml 1280 1282 1280 1282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1396 1398 1381 1383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hi</sup>
###xml 1427 1434 1412 1419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3B</xref>
###xml 40 44 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 417 421 <span type="species:ncbi:10090">mice</span>
###xml 680 684 <span type="species:ncbi:10090">mice</span>
###xml 1169 1173 <span type="species:ncbi:10090">mice</span>
###xml 1262 1266 <span type="species:ncbi:10090">mice</span>
Thymus cellularity of 4- to 12-week old mice, deficient for either APP or APLP2, was not significantly different from that of their WT littermates, but absolute numbers were decreased in the APP-/-APLP2-/- mice (Fig. 3A and Table 1). However, when mice are stressed by poor health, it is common for thymus cellularity to be reduced due to an increased production of endogenous steroids. Although the double-deficient mice had a global reduction in thymocyte numbers, there was no indication of a developmental block by subset or linage analysis This interpretation was supported by the fact that the relative proportion of all subsets/lineages were comparable in APP and/or APLP2 mice (Table 1). Mean percentages of thymocytes at each distinct stage of development, double negative (DN, CD4-CD8-), double positive (DP, CD4+CD8+) and CD4 and CD8 SP, were all normal (Fig. 3B, top panels), and in the absence of APP and/or APLP2, there was no evidence of an accumulation of DN thymocytes. The relative contribution of each DN subset, DN1 (CD44+CD25-), DN2 (CD44+CD25+), DN3 (CD44-CD25+) and DN4 (CD44-CD25-) was unaffected (Fig. 3B, middle panels), and in APP-/-APLP2-/- mice, the absolute number of all four subsets was similarly reduced (Table 1). WT and mutant mice generated TCRhi mature thymocytes with similar frequency and the percentages of alphabeta or gammadelta thymocytes within the TCRhi population were equivalent (Fig. 3B, bottom panels). Thus, T cell development proceeded normally with no evidence of a block at any stage, indicating that neither APP nor APLP2 are required for thymocyte maturation.
###end p 38
###begin p 39
###xml 138 139 138 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table-fn" rid="tblfn1">a</xref>
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Analysis of absolute cell number and relative proportion of thymocyte subsets in adult mice deficient in amyloid precursor family proteinsa
###end p 39
###begin p 40
###xml 44 45 42 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 63 64 59 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 74 77 70 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 77 78 73 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 90 93 86 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 93 94 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 108 111 104 107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 116 119 112 115 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 119 120 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 151 152 147 148 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 197 198 193 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
Values represent arithmetic means +/- SEM; *P </= 0.03; for WT n = 32, APP-/-n = 26, APLP2-/-n = 18, and APP-/-APLP2-/-n = 5, with the exception of Lin- (lineage negative, as described in Methods) n = 5 for each genotype.
###end p 40
###begin p 41
###xml 163 164 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 173 174 173 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 183 186 183 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 199 202 199 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 256 257 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 303 304 303 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 523 524 500 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 642 646 <span type="species:ncbi:10090">mice</span>
APP and/or APLP2 are not required for normal thymocyte development from adult precursors. (A) Total thymus cellularity was calculated for 4- to 12-week old WT (APP+ or APLP2+) and APP-/- and/or APLP2-/- mice, as indicated. Asterisk denotes significance by t-test, P = 0.02. (B) Cells were gated for CD45+ and analysed for expression of CD4 and CD8alpha (top), gated to exclude cells expressing CD4, CD8alpha, CD19, TCRalphabeta and TCRgammadelta (Lin-) and analysed for expression of CD44 and CD25 (middle) or gated for CD3+ and analysed for expression of TCRalphabeta and TCRgammadelta (bottom). The data are representative of at least five mice analysed for each genotype.
###end p 41
###begin p 42
###xml 30 33 30 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 40 43 40 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 136 142 136 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
###xml 152 153 152 153 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 416 417 394 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 420 421 398 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
In the periphery, LNs from APP-/-, APLP2-/- and APP-/-APLP2-/- mice all contained mature T and B lymphocytes at the expected frequency (Fig. 4). The CD3+ T cell populations were normal, composed primarily of alphabeta T cells with <2% of cells expressing TCRgammadelta (data not shown). Within the alphabeta T lineage, CD8 and CD4 T cells were present at normal frequencies, and LN B cells had the expected naive IgM+IgD+ phenotype. Taken together, these results indicate no role for APP family members in the development of lymphocytes originating from adult precursors.
###end p 42
###begin p 43
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 189 190 182 183 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 443 447 <span type="species:ncbi:10090">mice</span>
Mature T and B cells appear normally in LNs in the absence of APP and/or APLP2. LN cells were gated for CD45+ and analysed for expression of CD3 and CD19 (first row), gated for TCRalphabeta+ cells and analysed for expression of CD4 and CD8alpha (second row) or analysed for expression of CD19 and IgM (third row). Cells co-expressing CD19 and IgM were analysed for expression of IgD (fourth row). The data are representative of at least three mice for each genotype.
###end p 43
###begin title 44
Neither APP nor APLP2 are required for thymocyte development from fetal precursors
###end title 44
###begin p 45
###xml 29 37 29 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 151 152 147 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 153 154 149 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
Several groups have utilized in vitro fetal thymus organ culture systems to assess the effects of gamma-secretase inhibitors on thymocyte development (1,2). It is noteworthy in this regard that thymocytes developing in embryonic day 14-15.5, fetal thymus are derived from fetal liver precursors, whereas thymocytes of adults are derived from bone marrow. Thus, while APP and/or APLP2 were not needed for adult thymocyte development, it was possible that these proteins could be required for fetal development.
###end p 45
###begin p 46
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 143 146 143 146 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 219 222 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 227 230 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 454 455 454 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 465 472 465 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5A</xref>
###xml 582 583 575 576 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 600 601 585 586 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 627 634 612 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5B</xref>
###xml 371 375 <span type="species:ncbi:10090">mice</span>
To assess T cell development from fetal liver precursors, thymocytes isolated from newborn APP- APLP2-deficient pups were analysed. APP-/-APLP2-/- pups were born with less than the predicted Mendelian frequency, and APP-/-APLP2-/- neonates often had less milk in their stomach consistent with neurological deficits impairing their ability to suckle. In contrast to adult mice, only subtle differences in thymus cellularity were observed in the newborns (P > 0.05) (Fig. 5A). Phenotypic analyses of newborns revealed that all CD4/CD8 thymocyte subsets, as well as mature TCRalphabeta+ or TCRgammadelta+ thymocytes, were normal (Fig. 5B), similar to adults. Therefore, APP and APLP2 are dispensable for T cell maturation from fetal or adult precursors.
###end p 46
###begin p 47
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 223 224 223 224 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 284 285 284 285 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 375 378 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 401 405 <span type="species:ncbi:10090">mice</span>
###xml 438 442 <span type="species:ncbi:10090">mice</span>
APP and/or APLP2 are not required for normal thymocyte development in neonates. (A) Total thymus cellularity was calculated for newborn mice (P-values revealed no significant differences). (B) Thymocytes were gated for CD45+ and analysed for expression of CD4 and CD8 (top) or for CD3+ and analysed for expression of TCRalphabeta and TCRgammadelta (bottom). Because the APLP2-/- were equivalent to WT mice by every criteria tested, these mice were used as littermate controls since they were generated in the same cross.
###end p 47
###begin title 48
APP or APLP2 deficiency does not confer a survival advantage to thymocytes
###end title 48
###begin p 49
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 336 343 336 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 501 508 501 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 618 625 618 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6A</xref>
###xml 858 859 858 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 869 876 869 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6B</xref>
###xml 308 312 <span type="species:ncbi:10090">mice</span>
APP is a positive regulator of programmed cell death. Forced expression of the intracellular domain of APP lowers the threshold for Fas-associated death in Jurkat T cells and induces apoptosis in HeLa and MCF7 cells (42). To determine sensitivity to programmed cell death, thymocytes of APP- APLP2-deficient mice were analysed directly ex vivo or at various times after culture in media in the absence of stromal cells or exogenous cytokines. The frequency of thymocytes undergoing apoptosis directly ex vivo or throughout the 4-day culture period was similar as determined by Annexin V and propidium iodide staining (Fig. 6A, and data not shown). Based on the ability to exclude Trypan Blue, absolute numbers of live cells remaining after culture were also assayed. At no time point was the mean number of live thymocytes recovered significantly different (P > 0.26) (Fig. 6B). Thus, in spite of a putative pro-apoptotic function for these proteins, the absence of APP and/or APLP2 did not confer a survival advantage to thymocytes.
###end p 49
###begin p 50
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ex vivo</italic>
###xml 356 357 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Absence of APP and/or APLP2 confers no survival advantage on thymocytes. (A) Thymocytes were stained for Annexin V and propidium iodide ex vivo, or at various times after culture. (B) The number of live thymocytes harvested daily from cell culture was determined by Trypan Blue exclusion. Data represent the mean percentage of live cells remaining +/-SEM. P > 0.2 for all time points.
###end p 50
###begin title 51
Discussion
###end title 51
###begin p 52
###xml 136 137 132 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 138 139 134 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib2">2</xref>
Studies using fetal thymus organ cultures demonstrate that gamma-secretase inhibitors interrupt thymocyte maturation at several points (1,2). First, the transition of DN to DP thymocytes is impaired, and in late T cell development, the maturation of CD8 SP thymocytes is impeded. The end result is reduced thymus cellularity and an accumulation of DN thymocytes. These studies indicate that the activity of one or more of the gamma-secretase substrates is important for T cell development. Moreover, they suggest that gamma-secretase inhibitors, developed for treatment of Alzheimer's disease, could have immunosuppressive effects. APP family proteins were potentially the substrates affected because of the functions ascribed to these proteins as well as their reported expression in thymus. Thus, identifying gamma-secretase substrates that operate in thymocyte development is important for elucidating the signals that drive differentiation and control cell fate. More significantly, identifying the target activities of gamma-secretase inhibitors could aid in the development of more specific drugs for treating Alzheimer's disease with fewer immunosuppressive side effects.
###end p 52
###begin p 53
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 634 640 <span type="species:ncbi:10090">murine</span>
From our results, it can be inferred that the inhibitors used in fetal thymus organ culture must have interfered with the processing of gamma-secretase substrates other than APP/APLP2. We find that newborn mice deficient for APP and/or APLP2 had normal thymus cellularity and CD4/CD8 subsets. Moreover, adult mutant mice had a normal frequency of mature T and B cells in LNs. Efficient thymocyte development in APP- and/or APLP2-deficient mice, coupled with the absence of detectable APP, APLP1 or APLP2 protein expression by thymocytes or peripheral lymphoid cells, demonstrate that APP family members do not play a critical role in murine lymphocyte development. An important implication of these results is that pharmacological inhibitors that specifically inhibit cleavage of APP should not adversely affect lymphocyte development.
###end p 53
###begin p 54
###xml 171 173 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 545 547 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">54</xref>
###xml 548 550 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">55</xref>
###xml 782 784 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">56</xref>
###xml 785 787 765 767 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">57</xref>
The first gamma-secretase inhibitor described in 1998 was a transition state analog that worked by binding to and blocking the active site of the gamma-secretase complex (19). Since then, numerous other gamma-secretase inhibitors have been developed that work by a variety of mechanisms. The data presented here suggest that inhibitors that specifically interfere with gamma-secretase-mediated APP cleavage are unlikely to have immunosuppressive side effects. Similarly, inhibitors that interfere with the first (BACE-mediated) cleavage of APP (54,55), rather than the second gamma-secretase-mediated cleavage, are unlikely to have immunosuppressive side effects on lymphocyte development or function. Consistent with this notion, BACE-deficient animals have no reported phenotype (56,57).
###end p 54
###begin p 55
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 251 253 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 881 883 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 761 766 <span type="species:ncbi:10090">mouse</span>
###xml 815 819 <span type="species:ncbi:10116">rats</span>
Our initial experiments using lysates of thymocyte cell suspensions revealed that mouse thymocytes do not express significant levels of APP or APLP2 protein. These findings were surprising in light of previous reports of mRNA expression in thymus (20,22-26). However, the earlier studies examined RNA prepared from intact thymus which recovers most of the stromal cells as well as the thymocytes. This discrepancy was reconciled when we prepared lysates from intact thymus or stained sections of frozen thymus. In assays that efficiently recover thymic stromal cells, it was clear that APLP2 protein was highly expressed and APP protein, at much lower levels. The latter results are consistent with findings that APP and APLP2 transcripts are both expressed in mouse thymus, with APLP2 > APP mRNA (23). Notably, in rats APP is reported to be expressed by astrocytes and microglia (22). The expression of APP in these myeloid cell types is consistent with our finding of APP and APLP2 in non-lymphoid cells of thymus and LN.
###end p 55
###begin p 56
###xml 258 260 258 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">58</xref>
###xml 418 420 418 420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 421 423 421 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">59</xref>
###xml 743 745 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
###xml 171 176 <span type="species:ncbi:10090">mouse</span>
###xml 246 249 <span type="species:ncbi:10116">rat</span>
###xml 287 292 <span type="species:ncbi:9606">human</span>
###xml 431 436 <span type="species:ncbi:9606">human</span>
###xml 1098 1104 <span type="species:ncbi:10090">murine</span>
###xml 1109 1114 <span type="species:ncbi:9606">human</span>
###xml 1206 1210 <span type="species:ncbi:10090">mice</span>
###xml 1215 1221 <span type="species:ncbi:9606">humans</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
Using newly developed antisera specific for each member of the APP family, we were able to show for the first time that APP, APLP1 and APLP2 proteins are not expressed in mouse lymphocytes. Consistent with these data, APP mRNA is not detected in rat spleen (58). Most reports agree that human peripheral blood lymphocytes do not express APP constitutively, but APP can be induced in response to mitogenic stimulation (22,59). Some human T-lymphoma cell lines express APP, while other T cell lines do not. However, several issues must be considered when interpreting these data. Studies conducted prior to the cloning of APLP2 used antisera raised against the C-terminus of APP. Many of those antisera were later found to cross-react on APLP2 (23), making it unclear which protein(s) were detected. Moreover, in light of our present findings that APP and APLP2 are expressed by non-lymphoid cells in thymus and LN, the contribution of non-lymphoid cell in those preparations complicates any conclusions regarding lymphocyte expression. If, however, the dichotomy in APP/APLP2 expression patterns by murine and human lymphocytes is confirmed, then there may be fundamental differences in APP biology between mice and humans that must be taken in to account when developing experimental models for studying Alzheimer's disease in mice.
###end p 56
###begin p 57
###xml 525 527 525 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">60</xref>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 436 439 <span type="species:ncbi:10116">rat</span>
The significance of APP family protein expression in thymic stromal cells is unclear. Although thymic stromal cells provide essential signals for thymocyte maturation, T cells of APP-/APLP2-deficient mice develop normally. Identifying a role for APP and APLP2 in stromal cells could help in determining the physiological function of APP family members. Of relevance, a punctate staining pattern of APP on the cell surface of neurons in rat brain led to the hypothesis that APP mediates cell-cell or cell-matrix interactions (60). Therefore, if ligands of APP and APLP are discovered, it would be of interest to determine whether they are expressed by thymocytes.
###end p 57
###begin p 58
###xml 361 362 361 362 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">0</sub>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">61</xref>
###xml 467 469 467 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">62</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 620 622 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 979 981 979 981 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
APP and APLP2 mRNA have been found in all tissues examined to date. However, because of a potential role in Alzheimer's disease, most of the work investigating APP associations has been conducted using neuronal cells. As a result, many of the proteins found to associate with the intracellular domain of APP are specifically expressed by neurons. For example, G0 is a brain-specific G protein (61), and expression of ShcC is restricted to the central nervous system (62). The intracellular domain of APP also associates with the nuclear adaptor protein Fe65 and Tip60 to form a complex that stimulates transcription (29-31). In this report, we have shown that APLP2 is highly expressed by stromal cells in both primary and secondary lymphoid tissues. It remains to be determined what proteins interact with APP/APLP2 in non-neuronal cell types and the function of these associations especially since the specific outcome of APP cleavage has been shown to be cell type dependent (42).
###end p 58
###begin p 59
###xml 640 642 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 723 725 711 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">64</xref>
###xml 953 955 937 939 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">60</xref>
###xml 956 958 940 942 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">65</xref>
###xml 959 961 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">68</xref>
###xml 1214 1215 1195 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 1216 1218 1197 1199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib69">69</xref>
###xml 1219 1221 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib73">73</xref>
###xml 717 721 <span type="species:ncbi:10090">mice</span>
We have demonstrated that APP family proteins are not expressed in T lineage cells. This finding effectively excludes these proteins from the list of gamma-secretase substrates that are required for normal T cell development. There are, however, several other gamma-secretase substrates to be considered. Expression of substrates, ErbB4, Nectin-1alpha and LRP, by lymphocytes has not been reported, but immature T cells do express E-cadherin and CD44. Although E-cadherin plays a critical role in the development of a functional thymic environment, it is not required for thymocyte maturation within an established thymus microenvironment (63). Moreover, T and B cells develop and function normally in CD44-deficient mice (64). Recent data suggest that the most likely explanation for gamma-secretase-mediated inhibition of thymocyte development is due to interference with Notch signaling. It is well established that Notch is expressed by thymocytes (60,65-68). In addition, Notch signaling is required for commitment of lymphoid precursors to the T cell lineage and for later stages of T cell development, including TCRbeta selection of thymocytes and functional differentiation of peripheral CD4 helper cells (7,69-73).
###end p 59
###begin title 60
Funding
###end title 60
###begin p 61
###xml 0 70 0 70 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">National Institutes of Health Intramural Research Program of the NIAID</funding-source>
National Institutes of Health Intramural Research Program of the NIAID.
###end p 61
###begin title 62
Abbreviations
###end title 62
###begin p 63
amyloid precursor protein
###end p 63
###begin p 64
amyloid precursor-like protein 1
###end p 64
###begin p 65
amyloid precursor-like protein 2
###end p 65
###begin p 66
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
double negative (CD4-CD8-)
###end p 66
###begin p 67
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
double positive (CD4+CD8+)
###end p 67
###begin p 68
lymph node
###end p 68
###begin p 69
lipoprotein receptor-related protein
###end p 69
###begin p 70
National Institute of Allergy and Infectious Disease
###end p 70
###begin p 71
recombination-activating gene
###end p 71
###begin p 72
###xml 20 21 20 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 24 25 24 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 36 37 36 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
single positive (CD4+CD8- or CD4-CD8+)
###end p 72
###begin p 73
wild type
###end p 73
###begin p 74
###xml 43 47 <span type="species:ncbi:10090">mice</span>
We thank Robert Cappai for providing APLP2 mice and assistance with genotyping protocols. We appreciate the expert assistance provided by Owen Schwartz of the NIAID Biological Imaging Facility. We thank Luciano D'Adamio and Pam Schwartzberg for helpful discussions and critical reading of the manuscript.
###end p 74
###begin article-title 75
Presenilin-dependent gamma-secretase activity modulates thymocyte development
###end article-title 75
###begin article-title 76
gamma-Secretase inhibitors repress thymocyte development
###end article-title 76
###begin article-title 77
Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation
###end article-title 77
###begin article-title 78
Notch 1 signaling regulates peripheral T cell activation
###end article-title 78
###begin article-title 79
TCR-mediated Notch signaling regulates proliferation and IFNgamma production in peripheral T cells
###end article-title 79
###begin article-title 80
Notch signaling augments T cell responsiveness by enhancing CD25 expression
###end article-title 80
###begin article-title 81
###xml 36 43 36 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 48 56 48 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Inhibitors of gamma-secretase block in vivo and in vitro T helper type 1 polarization by preventing Notch upregulation of Tbx21
###end article-title 81
###begin article-title 82
Processing of the Notch ligand delta by the metalloprotease Kuzbanian
###end article-title 82
###begin article-title 83
Gamma-secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase
###end article-title 83
###begin article-title 84
A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions
###end article-title 84
###begin article-title 85
Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain
###end article-title 85
###begin article-title 86
Nectin-1alpha, an immunoglobulin-like receptor involved in the formation of synapses, is a substrate for Presenilin/gamma-secretase-like cleavage
###end article-title 86
###begin article-title 87
The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase
###end article-title 87
###begin article-title 88
The Notch ligands, Delta1 and Jagged2, are substrates for Presenilin-dependent "gamma -secretase" cleavage
###end article-title 88
###begin article-title 89
The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and Presenilin/gamma-secretase and release signaling fragments
###end article-title 89
###begin article-title 90
Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44
###end article-title 90
###begin article-title 91
Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an A beta-like peptide
###end article-title 91
###begin article-title 92
Sequential processing of the transmembrane chemokines CX3CL1 and CXCL16 by alpha- and gamma-secretases
###end article-title 92
###begin article-title 93
A substrate-based difluoro ketone selectively inhibits Alzheimer's gamma-secretase activity
###end article-title 93
###begin article-title 94
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40,000 molecular weight receptor-associated protein
###end article-title 94
###begin article-title 95
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Identification of a mouse brain cDNA that encodes a protein related to the Alzheimer disease-associated amyloid beta protein precursor
###end article-title 95
###begin article-title 96
Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells
###end article-title 96
###begin article-title 97
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP)
###end article-title 97
###begin article-title 98
###xml 94 97 <span type="species:ncbi:10116">rat</span>
Beta A4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including brain, but not in neurons
###end article-title 98
###begin article-title 99
Similar alternative splicing of a non-homologous domain in beta A4-amyloid protein precursor-like proteins
###end article-title 99
###begin article-title 100
###xml 34 39 34 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">APLP2</italic>
Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid protein precursor
###end article-title 100
###begin article-title 101
Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription
###end article-title 101
###begin article-title 102
Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch
###end article-title 102
###begin article-title 103
The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein
###end article-title 103
###begin article-title 104
The regions of the Fe65 protein homologous to the phosphotyrosine interaction/phosphotyrosine binding domain of Shc bind the intracellular domain of the Alzheimer's amyloid precursor protein
###end article-title 104
###begin article-title 105
A transcriptively active complex of APP with Fe65 and histone acetyltransferase Tip60
###end article-title 105
###begin article-title 106
A macromolecular complex involving the amyloid precursor protein (APP) and the cytosolic adapter FE65 is a negative regulator of axon branching
###end article-title 106
###begin article-title 107
Jun NH2-terminal kinase (JNK) interacting protein 1 (JIP1) binds the cytoplasmic domain of the Alzheimer's beta-amyloid precursor protein (APP)
###end article-title 107
###begin article-title 108
c-Jun N-terminal kinase (JNK)-interacting protein-1b/islet-brain-1 scaffolds Alzheimer's amyloid precursor protein with JNK
###end article-title 108
###begin article-title 109
Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK1,2 signaling
###end article-title 109
###begin article-title 110
The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids
###end article-title 110
###begin article-title 111
Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease
###end article-title 111
###begin article-title 112
A new paradigm for neurotoxicity by FAD mutants of beta-APP: a signaling abnormality
###end article-title 112
###begin article-title 113
Tyrosine phosphorylation of the beta-amyloid precursor protein cytoplasmic tail promotes interaction with Shc
###end article-title 113
###begin article-title 114
The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling
###end article-title 114
###begin article-title 115
A physiologic signaling role for the gamma-secretase-derived intracellular fragment of APP
###end article-title 115
###begin article-title 116
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid protein precursor
###end article-title 116
###begin article-title 117
JNK-interacting protein-1 promotes transcription of A-beta protein precursor but not A-beta precursor-like proteins, mechanistically different than Fe65
###end article-title 117
###begin article-title 118
Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein
###end article-title 118
###begin article-title 119
Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories
###end article-title 119
###begin article-title 120
Notch signaling in lymphocyte development and function
###end article-title 120
###begin article-title 121
###xml 41 45 <span type="species:ncbi:10090">mice</span>
beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity
###end article-title 121
###begin article-title 122
###xml 23 27 <span type="species:ncbi:10090">mice</span>
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice
###end article-title 122
###begin article-title 123
Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-Golgi compartments of hippocampal neurons
###end article-title 123
###begin article-title 124
A monoclonal antibody discriminating between subsets of T and B cells
###end article-title 124
###begin article-title 125
###xml 108 112 <span type="species:ncbi:10090">mice</span>
Age-related cognitive deficits, impaired long-term potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein
###end article-title 125
###begin article-title 126
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members
###end article-title 126
###begin article-title 127
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene
###end article-title 127
###begin article-title 128
Progress toward the discovery and development of efficacious BACE inhibitors
###end article-title 128
###begin article-title 129
Progress toward a practical BACE-1 inhibitor
###end article-title 129
###begin article-title 130
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation
###end article-title 130
###begin article-title 131
###xml 14 18 <span type="species:ncbi:10090">mice</span>
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics
###end article-title 131
###begin article-title 132
###xml 91 94 91 94 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">695</sub>
###xml 73 76 <span type="species:ncbi:10116">rat</span>
###xml 129 132 <span type="species:ncbi:10116">rat</span>
###xml 137 142 <span type="species:ncbi:9606">human</span>
Differential splicing of Alzheimer's disease amyloid A4 precursor RNA in rat tissues: preA4695 mRNA is predominantly produced in rat and human brain
###end article-title 132
###begin article-title 133
###xml 84 89 <span type="species:ncbi:9606">human</span>
Synthesis and secretion of Alzheimer amyloid beta4A precursor protein by stimulated human peripheral blood leukocytes
###end article-title 133
###begin article-title 134
###xml 70 73 <span type="species:ncbi:10116">rat</span>
Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact
###end article-title 134
###begin article-title 135
Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go
###end article-title 135
###begin article-title 136
A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain
###end article-title 136
###begin article-title 137
Involvement of E-cadherin in thymus organogenesis and thymocyte maturation
###end article-title 137
###begin article-title 138
CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity
###end article-title 138
###begin article-title 139
Notch-1 regulates NF-kB activity in hemopoietic progenitor cells
###end article-title 139
###begin article-title 140
Expression pattern of Notch1, 2 and 3 and Jagged1 and 2 in lymphoid and stromal thymus components: distinct ligand-receptor interactions in intrathymic T cell development
###end article-title 140
###begin article-title 141
Entry into the thymic microenvironment triggers Notch activation in the earliest migrant T cell progenitors
###end article-title 141
###begin article-title 142
Modulated expression of Notch1 during thymocyte development
###end article-title 142
###begin article-title 143
###xml 39 43 <span type="species:ncbi:10090">mice</span>
Deficient T cell fate specification in mice with an induced inactivation of Notch1
###end article-title 143
###begin article-title 144
###xml 84 92 84 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Induction of T cell development from hematopoietic progenitor cells by Delta-like-1 in vitro
###end article-title 144
###begin article-title 145
Regulation of alphabeta/gammadeltaT cell lineage commitment and peripheral T cell responses by Notch/RBP-J signaling
###end article-title 145
###begin article-title 146
Obligatory role for cooperative signaling by pre-TCR and Notch during thymocyte differentiation
###end article-title 146
###begin article-title 147
Instruction of distinct CD4 T helper cell fates by different Notch ligands on antigen-presenting cells
###end article-title 147

